Hormonal condition prevalence by life stage
Visual heatmap. Conditions (rows) × life stages (columns) × prevalence (color). Highlights when to screen for what. Editorial estimates from clinical literature.
| Condition | Teens | 20s | 30s | 40s | 50s | 60s+ |
|---|---|---|---|---|---|---|
| PCOS | H | P | P | H | M | L |
| Endometriosis | M | P | P | H | L | R |
| Hypothyroid | L | M | H | H | H | H |
| Hyperthyroid | L | M | M | M | L | L |
| Perimenopause | R | R | L | P | M | R |
| Menopause | R | R | R | L | P | M |
| Postmeno bone loss | R | R | R | R | M | P |
| Insulin resistance | L | M | H | P | P | H |
| Obesity / weight gain | M | H | H | P | P | H |
| Hot flashes / VMS | R | R | R | H | P | M |
| Vaginal atrophy | R | R | R | M | P | P |
| Cardiovascular risk | R | R | L | M | H | P |
Legend
RareLowModerateHighPeak
Use this for screening conversations
Bring this to your annual visit. If a condition is "High" or "Peak" in your stage, ask whether screening is appropriate. Editorial estimates — verify with your clinician.